Arsen O. Rasulov

Arsen O. Rasulov

Auto-generated profile, based on publicly available information

Arsen O. Rasulov

Clinical Hospital “Lapino” of the “Mother and Child” Group of companies

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2016 in Techniques in Coloproctology
Verified
Journal Article
Closed access
PDF file
ARA. O. Rasulov
A. O. Rasulov
ZMZ. Z. Mamedli
Z. Z. Mamedli
SGS. S. Gordeyev
S. S. Gordeyev
NKN. A. Kozlov
N. A. Kozlov
HDH. E. Dzhumabaev
H. E. Dzhumabaev

1 August 2015 in Bulletin of the Lebedev Physics Institute
Verified
Journal Article
Closed access
PDF file
MDM. I. Davydov
M. I. Davydov
VSV. Yu. Sel’CHuk
V. Yu. Sel’CHuk
VNV. G. Nikitaev
V. G. Nikitaev
ONO. V. Nagornov
O. V. Nagornov
APA. N. Pronichev
A. N. Pronichev
VSV. E. Strigin
V. E. Strigin
The problems of using physical research methods in diagnostics of oncological diseases of the gastrointestinal tract and constructing a multimedia learning system on their basis for doctors are...

6 December 2016 in International Journal of Hyperthermia
Verified
Journal Article
Closed access
ARA. O. Rasulov
A. O. Rasulov
SGS. S. Gordeyev
S. S. Gordeyev
YBYu. A. Barsukov
Yu. A. Barsukov
STS. I. Tkachev
S. I. Tkachev
AMA. G. Malikhov
A. G. Malikhov
MFM. Yu. Fedyanin
M. Yu. Fedyanin
Purpose: The aim of this study was to investigate the feasibility of short-course radiotherapy with oral capecitabine, hyperthermia and delayed surgery for neoadjuvant treatment of rectal cancer. Methods: Patients with clinically staged T2-3N0-2M0 primary rectal cancer were included. All patients received short-course 25 Gy in 5 Gy fractions radiotherapy with capecitabine, local hyperthermia and metronidazole. Capecitabine 1000 mg/m2 twice a day was given on days 1–14. Local hyperthermia, 41–45 °C for 60 min, was performed on days 3–5. Metronidazole 10 g/m2 was administered per rectum on days 3 and 5. The time interval to surgery was not less than four weeks after neoadjuvant treatment. The primary end-point was pathological complete response (pCR). Secondary end-points included neoadjuvant treatment toxicity, tumour regression, surgical and oncological outcomes. Results: A total of 81 patients were included in the analysis. Ten (12.3%) patients had grade 3 toxicity and one (1.2%) patient had grade 4 toxicity. Sphincter-sparing surgery was performed for 78 (96.3%) patients. There was no postoperative mortality. Postoperative complications occurred in 11 (13.8%) patients. Sixteen (20%) patients had a pCR. The median follow-up was 40.9 months. There were no local recurrences. Nine (11.1%) patients developed distant metastases. Three-year overall survival was 97% and the three-year disease-free survival was 85%. Conclusions: Short-course radiotherapy with chemotherapy, radiosensitizers and delayed surgery is a feasible treatment for rectal cancer and may lead to tumour regression rate comparable with long-course chemoradiation.

1 August 2017 in Cancer Chemotherapy and Pharmacology
Verified
Journal Article
Closed access
PDF file
SGSergey S. Gordeyev
Sergey S. Gordeyev
ARArsen O. Rasulov
Arsen O. Rasulov
VGVera A. Gorbounova
Vera A. Gorbounova
STSergey I. Tkachev
Sergey I. Tkachev
VGValeriya V. Glebovskaya
Valeriya V. Glebovskaya
YSYulia E. Surayeva
Yulia E. Surayeva

1 January 2016 in Pirogov Russian Journal of Surgery
Verified
Journal Article
Closed access
ARA. O. Rasulov
A. O. Rasulov
ZMZ. Z. Mamedli
Z. Z. Mamedli
KDKh. E. Dzhumabaev
Kh. E. Dzhumabaev
VKV. M. Kulushev
V. M. Kulushev
NKN. A. Kozlov
N. A. Kozlov
To evaluate and compare intraoperative features, early surgical outcomes, quality of excised specimen after laparoscopic and transanal total mesorectal excision (LA-TME and TA-TME).

23 October 2018 in European Surgery
Verified
Journal Article
Closed access
PDF file
SGS. S. Gordeyev
S. S. Gordeyev
KDK. E. Dzhumabaev
K. E. Dzhumabaev
ZMZ. Z. Mamedli
Z. Z. Mamedli
NKN. A. Kozlov
N. A. Kozlov
YSY. E. Surayeva
Y. E. Surayeva
ARA. O. Rasulov
A. O. Rasulov